Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/10256/13440
dc.contributor.author | Vert Company, Anna |
---|---|
dc.contributor.author | Castro Gallegos, Jessica |
dc.contributor.author | Ribó i Panosa, Marc |
dc.contributor.author | Benito i Mundet, Antoni |
dc.contributor.author | Vilanova i Brugués, Maria |
dc.date | 2017-01-24T08:12:49Z |
dc.date | 2017-01-24T08:12:50Z |
dc.date | 2016-12-27 |
dc.identifier.citation | 1949-2553 |
dc.identifier.citation | 026110 |
dc.identifier.uri | http://hdl.handle.net/10256/13440 |
dc.format | application/pdf |
dc.language.iso | eng |
dc.relation | https://doi.org/10.18632/oncotarget.14302 |
dc.relation | Reproducció digital del document publicat a: https://doi.org/10.18632/oncotarget.14302 |
dc.relation | Oncotarget, 2016 |
dc.relation | Articles publicats (D-B) |
dc.rights | Reconeixement 3.0 Espanya |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by/3.0/es |
dc.source | Vert Company, Anna Castro Gallegos, Jessica Ribó i Panosa, Marc Benito i Mundet, Antoni Vilanova i Brugués, Maria 2016 Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of onconase Oncotarget |
dc.subject | Ribonucleases |
dc.subject | Medicaments antineoplàstics |
dc.subject | Antineoplastic agents |
dc.subject | Medicaments antivírics |
dc.subject | Antiviral agents |
dc.title | Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of onconase |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |